TITLE

Strategies of drug companies to optimize the sales of their psychiatric drugs

PUB. DATE
January 2007
SOURCE
BMC Psychiatry;2007 Supplement 1, Vol. 7, pS1-S90
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43708627

 

Related Articles

  • The price on pain. Quinlivan, Beth // BRW;9/6/2001, Vol. 23 Issue 35, p42 

    Examines key issues and developments relevant to drug prices in Australia. Sales and marketing strategies; Costs of drugs; Drug manufacturing processes; Implications for pharmaceutical companies.

  • Roots of success run deep. Buckley, Bruce // Drug Store News;4/29/2002, Vol. 24 Issue 6, p107 

    Features the Gouverneur, New York-based drug store chain operator, Kinney Drugs Incorporated. Company's sales growth in 2001; Merchandising strategy of Kinney Drugs; Information on the automated prescription dispensing system at Kinney Drugs.

  • AstraZeneca predicts top-tier earnings.  // Medical Marketing & Media;Nov2003, Vol. 38 Issue 11, p10 

    Focuses on the optimism of pharmaceutical company AstraZeneca on achievement of sales goals in the U.S. Result of the annual business review; Sales of new drugs.

  • Pricing of prescription drugs and its impact on physicians’ choice behavior. Chen Miao-Sheng; Shih Yu-Ti // Health Care Management Science;Sep2008, Vol. 11 Issue 3, p288 

    This research presents an analysis of Taiwan’s health care market with the focus on the pricing of prescription drugs and its impact on physicians’ choice behavior. Since the advent of Taiwan’s national health insurance, with the competent authority being Bureau of National...

  • Two billion-dollar chains prosper by staying true to course. Griffin, Marie // Drug Store News;3/26/2001, Vol. 23 Issue 4, p7 

    Comments on the business operation of drug chain companies Duane Reade and Brooks Pharmacy. Sales posted by the companies; Comparison of their management strategies; Competition between the drug chains; Markets served by the companies.

  • Sneezin' season rings up sales. Wilke, Michael // Advertising Age;9/18/1995, Vol. 66 Issue 37, p1 

    Reports on the efforts of drug companies to woo customers suffering from sneezing allergy due to bad fall weather conditions. Marketing strategies and sales of various drug companies including Glaxo Wellcome, Seldane and several others.

  • There's Something About Mary.  // Chain Store Age;Dec2001, Vol. 77 Issue 12, p39 

    Focuses on the plans of Rite Aid President Mary Sammons for the company's drug stores in the U.S. Strategy for increasing sales of generic drugs; Efforts of the company to cut costs.

  • Peddling paranoia. Cassels, Alan // New Internationalist;Nov2003, Issue 362, p16 

    Reports on the business strategies of pharmaceutical companies in selling cures for imaginary diseases in the U.S. Actions taken to convince consumer of the efficacy of the drug; Employment of public relations agencies to increase sales; Concerns over the safety of the drugs.

  • Brazilian drugs show signs of health. Salles, Flavio // Chemical Week;11/13/1996, Vol. 158 Issue 44, p44 

    Focuses on the growth of Brazil's pharmaceutical industry. Increase in sales in 1995; Expansion plans by several drug companies in the country; Pharmacia & Upjohn's strategy for renegotiating licensing contracts with Rhodia Farma; Top drug sellers in Brazil.

  • ‘Unfortunately strong [pipelines] can become weak quickly and vice versa. Sometimes things don't persist.’. Krensavage, Michael // Indianapolis Business Journal;11/1/2004, Vol. 25 Issue 34, p48 

    Reports on the strategy of drug manufacturer Eli Lilly & Co. to combat the declining sales of the company in the U.S. Reduction of unnecessary expenses by retrenching employees; Promotion of the drug Zyprexa; Elimination of research projects with small odds of success.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics